Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MRC Technology and Renishaw Diagnostics Collaborate

Published: Thursday, October 03, 2013
Last Updated: Thursday, October 03, 2013
Bookmark and Share
Initiative combines expertise to accelerate clinical diagnostic screening.

MRC Technology announced it has entered into collaboration with Renishaw Diagnostics Ltd (RDL), developer of the RenDx® multiplex assay system, to identify and design novel clinical diagnostic tests for infectious disease.

The agreement will benefit from the combination of RDL’s proprietary multiplex screening technology and expertise in assay development, with MRC Technology’s experience in developing early stage research for clinical application and commercialisation. The focus of the collaboration is to identify and accelerate research which has potential in infectious disease diagnostics.

Rupert Jones, RDL’s General Manager commented, “RDL is delighted to be working with MRC Technology as a leader in translating basic research into commercial opportunities. MRC Technology's expertise and experience will allow us to accelerate development of our assay portfolio, enhancing the capabilities of the RenDx platform and providing end users with additional value and flexibility.”

The RenDx multiplex assay system is based on surface enhanced resonance Raman scattering, providing automated, multiplex, high sensitivity, in vitro screening for clinical research.

“MRC Technology will build a capability in early stage translation of diagnostic opportunities from academia at our laboratory facilities in Edinburgh,” added Mike Dalrymple, MRC Technology. “We are delighted to be working with RDL to identify opportunities that will take advantage of RDL’s platform and capabilities. Key to success will be ensuring information exchange between RDL and MRC Technology scientists, thus opening up the potential for future research collaboration.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MRC Technology Launches Respiratory ‘Call for Targets’
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease.
Monday, March 02, 2015
Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases
MRC Technology to lead Neurodegeneration Medicines Acceleration Programme to uncover promising drugs in pharma libraries.
Tuesday, November 18, 2014
MRC Technology Negotiates License with Bio-Techne for MRC’s GOPAL Protein Synthesis Technology
Technology enables production of ubiquitin reagents and other proteins for use in drug discovery.
Wednesday, August 27, 2014
MRC Technology, AstraZeneca Renew Target Discovery Collaboration
Initiative brings together global expertise to share compound libraries and streamline drug discovery.
Thursday, July 03, 2014
MRC Technology Sells its MCRs Programme to Pfizer
Small molecules developed in collaboration with Queen Mary University of London.
Thursday, June 19, 2014
MRC Technology, Daiichi Sankyo form Drug Discovery Collaboration
Initiative brings together global expertise to streamline drug discovery.
Wednesday, May 14, 2014
£3m Dementia Consortium Launched
New Consortium aims to boost dementia drug discovery by uniting charity, academic and private sectors in search for new treatments.
Wednesday, December 11, 2013
MRC Technology and Oxford University Collaborate
The project will screen TRESK potassium channel activators involved in migraine pain control.
Thursday, November 14, 2013
MRC Technology Forms Alliance with World Leading Translational Research Centres
The aim of this alliance is to strengthen the international academic and/or not-for-profit drug development and commercialization network.
Monday, January 21, 2013
MRC Technology Launches Small Molecule Compound Library Access Scheme
Subset of compound library to be made available to academic researchers free of charge.
Thursday, September 20, 2012
Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!